nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Doxorubicin—NOS3—systemic scleroderma	0.0164	1	CrCbGaD
Valrubicin—TOP2A—Methyltestosterone—Prednisone—systemic scleroderma	0.00683	1	CbGdCrCtD
Valrubicin—Bladder pain—Lisinopril—systemic scleroderma	0.00586	0.00599	CcSEcCtD
Valrubicin—Urinary tract infection—Mometasone—systemic scleroderma	0.00566	0.0058	CcSEcCtD
Valrubicin—Cystitis noninfective—Mycophenolate mofetil—systemic scleroderma	0.00554	0.00567	CcSEcCtD
Valrubicin—Urinary incontinence—Mycophenolate mofetil—systemic scleroderma	0.00548	0.00561	CcSEcCtD
Valrubicin—Cystitis—Mycophenolate mofetil—systemic scleroderma	0.00548	0.00561	CcSEcCtD
Valrubicin—Blood urea increased—Mycophenolate mofetil—systemic scleroderma	0.00536	0.00548	CcSEcCtD
Valrubicin—Pollakiuria—Captopril—systemic scleroderma	0.0053	0.00543	CcSEcCtD
Valrubicin—Flatulence—Pentoxifylline—systemic scleroderma	0.0052	0.00532	CcSEcCtD
Valrubicin—Bladder pain—Mycophenolate mofetil—systemic scleroderma	0.00513	0.00525	CcSEcCtD
Valrubicin—Back pain—Pentoxifylline—systemic scleroderma	0.0051	0.00522	CcSEcCtD
Valrubicin—Urinary retention—Mycophenolic acid—systemic scleroderma	0.00496	0.00508	CcSEcCtD
Valrubicin—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00489	0.00501	CcSEcCtD
Valrubicin—Anaemia—Pentoxifylline—systemic scleroderma	0.00488	0.00499	CcSEcCtD
Valrubicin—Malaise—Pentoxifylline—systemic scleroderma	0.00476	0.00487	CcSEcCtD
Valrubicin—Chest pain—Pentoxifylline—systemic scleroderma	0.00449	0.0046	CcSEcCtD
Valrubicin—Myalgia—Pentoxifylline—systemic scleroderma	0.00449	0.0046	CcSEcCtD
Valrubicin—Pneumonia—Azathioprine—systemic scleroderma	0.00449	0.0046	CcSEcCtD
Valrubicin—Irritability—Lisinopril—systemic scleroderma	0.00449	0.00459	CcSEcCtD
Valrubicin—Discomfort—Pentoxifylline—systemic scleroderma	0.00444	0.00454	CcSEcCtD
Valrubicin—Dysuria—Leflunomide—systemic scleroderma	0.00442	0.00453	CcSEcCtD
Valrubicin—Back pain—Mometasone—systemic scleroderma	0.0044	0.00451	CcSEcCtD
Valrubicin—Pollakiuria—Leflunomide—systemic scleroderma	0.00437	0.00447	CcSEcCtD
Valrubicin—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00427	0.00437	CcSEcCtD
Valrubicin—Pneumonia—Leflunomide—systemic scleroderma	0.00424	0.00434	CcSEcCtD
Valrubicin—Dysuria—Mycophenolic acid—systemic scleroderma	0.00422	0.00432	CcSEcCtD
Valrubicin—Pollakiuria—Mycophenolic acid—systemic scleroderma	0.00417	0.00427	CcSEcCtD
Valrubicin—Urinary tract infection—Leflunomide—systemic scleroderma	0.0041	0.0042	CcSEcCtD
Valrubicin—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00407	0.00417	CcSEcCtD
Valrubicin—Pneumonia—Mycophenolic acid—systemic scleroderma	0.00405	0.00414	CcSEcCtD
Valrubicin—Haematuria—Leflunomide—systemic scleroderma	0.00402	0.00412	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00392	0.00402	CcSEcCtD
Valrubicin—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00392	0.00401	CcSEcCtD
Valrubicin—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.00391	0.004	CcSEcCtD
Valrubicin—Chest pain—Mometasone—systemic scleroderma	0.00388	0.00397	CcSEcCtD
Valrubicin—Myalgia—Mometasone—systemic scleroderma	0.00388	0.00397	CcSEcCtD
Valrubicin—Haematuria—Mycophenolic acid—systemic scleroderma	0.00384	0.00393	CcSEcCtD
Valrubicin—Dysuria—Lisinopril—systemic scleroderma	0.0038	0.00389	CcSEcCtD
Valrubicin—Oedema peripheral—Leflunomide—systemic scleroderma	0.00373	0.00382	CcSEcCtD
Valrubicin—Ill-defined disorder—Captopril—systemic scleroderma	0.00371	0.0038	CcSEcCtD
Valrubicin—Anaemia—Captopril—systemic scleroderma	0.0037	0.00378	CcSEcCtD
Valrubicin—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00367	0.00375	CcSEcCtD
Valrubicin—Pneumonia—Lisinopril—systemic scleroderma	0.00364	0.00373	CcSEcCtD
Valrubicin—Malaise—Captopril—systemic scleroderma	0.00361	0.00369	CcSEcCtD
Valrubicin—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00356	0.00364	CcSEcCtD
Valrubicin—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00355	0.00363	CcSEcCtD
Valrubicin—Urinary tract infection—Lisinopril—systemic scleroderma	0.00352	0.00361	CcSEcCtD
Valrubicin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00352	0.0036	CcSEcCtD
Valrubicin—Haematuria—Lisinopril—systemic scleroderma	0.00345	0.00354	CcSEcCtD
Valrubicin—Myalgia—Captopril—systemic scleroderma	0.0034	0.00348	CcSEcCtD
Valrubicin—Chest pain—Captopril—systemic scleroderma	0.0034	0.00348	CcSEcCtD
Valrubicin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0034	0.00348	CcSEcCtD
Valrubicin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.0034	0.00348	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00338	0.00346	CcSEcCtD
Valrubicin—Discomfort—Captopril—systemic scleroderma	0.00336	0.00344	CcSEcCtD
Valrubicin—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00333	0.00341	CcSEcCtD
Valrubicin—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00329	0.00337	CcSEcCtD
Valrubicin—Flatulence—Leflunomide—systemic scleroderma	0.00325	0.00332	CcSEcCtD
Valrubicin—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00324	0.00331	CcSEcCtD
Valrubicin—Anaemia—Azathioprine—systemic scleroderma	0.00322	0.0033	CcSEcCtD
Valrubicin—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00321	0.00329	CcSEcCtD
Valrubicin—Oedema peripheral—Lisinopril—systemic scleroderma	0.0032	0.00328	CcSEcCtD
Valrubicin—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.00319	0.00327	CcSEcCtD
Valrubicin—Back pain—Leflunomide—systemic scleroderma	0.00319	0.00326	CcSEcCtD
Valrubicin—Malaise—Azathioprine—systemic scleroderma	0.00315	0.00322	CcSEcCtD
Valrubicin—Cystitis noninfective—Methotrexate—systemic scleroderma	0.00314	0.00321	CcSEcCtD
Valrubicin—Cystitis—Methotrexate—systemic scleroderma	0.0031	0.00318	CcSEcCtD
Valrubicin—Flatulence—Mycophenolic acid—systemic scleroderma	0.0031	0.00317	CcSEcCtD
Valrubicin—Asthenia—Pentoxifylline—systemic scleroderma	0.00309	0.00316	CcSEcCtD
Valrubicin—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00316	CcSEcCtD
Valrubicin—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00306	0.00313	CcSEcCtD
Valrubicin—Pruritus—Pentoxifylline—systemic scleroderma	0.00305	0.00312	CcSEcCtD
Valrubicin—Anaemia—Leflunomide—systemic scleroderma	0.00305	0.00312	CcSEcCtD
Valrubicin—Back pain—Mycophenolic acid—systemic scleroderma	0.00304	0.00311	CcSEcCtD
Valrubicin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00304	0.00311	CcSEcCtD
Valrubicin—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00303	0.0031	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00297	0.00304	CcSEcCtD
Valrubicin—Malaise—Leflunomide—systemic scleroderma	0.00297	0.00304	CcSEcCtD
Valrubicin—Myalgia—Azathioprine—systemic scleroderma	0.00297	0.00304	CcSEcCtD
Valrubicin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00295	0.00302	CcSEcCtD
Valrubicin—Abdominal pain—Mometasone—systemic scleroderma	0.00294	0.00301	CcSEcCtD
Valrubicin—Body temperature increased—Mometasone—systemic scleroderma	0.00294	0.00301	CcSEcCtD
Valrubicin—Discomfort—Azathioprine—systemic scleroderma	0.00293	0.003	CcSEcCtD
Valrubicin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00292	0.00299	CcSEcCtD
Valrubicin—Bladder pain—Methotrexate—systemic scleroderma	0.00291	0.00298	CcSEcCtD
Valrubicin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00291	0.00297	CcSEcCtD
Valrubicin—Dizziness—Pentoxifylline—systemic scleroderma	0.00285	0.00291	CcSEcCtD
Valrubicin—Malaise—Mycophenolic acid—systemic scleroderma	0.00283	0.0029	CcSEcCtD
Valrubicin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00287	CcSEcCtD
Valrubicin—Myalgia—Leflunomide—systemic scleroderma	0.00281	0.00287	CcSEcCtD
Valrubicin—Chest pain—Leflunomide—systemic scleroderma	0.00281	0.00287	CcSEcCtD
Valrubicin—Flatulence—Lisinopril—systemic scleroderma	0.00279	0.00286	CcSEcCtD
Valrubicin—Discomfort—Leflunomide—systemic scleroderma	0.00277	0.00284	CcSEcCtD
Valrubicin—Back pain—Lisinopril—systemic scleroderma	0.00274	0.0028	CcSEcCtD
Valrubicin—Vomiting—Pentoxifylline—systemic scleroderma	0.00274	0.0028	CcSEcCtD
Valrubicin—Rash—Pentoxifylline—systemic scleroderma	0.00271	0.00278	CcSEcCtD
Valrubicin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00271	0.00278	CcSEcCtD
Valrubicin—Headache—Pentoxifylline—systemic scleroderma	0.0027	0.00276	CcSEcCtD
Valrubicin—Feeling abnormal—Captopril—systemic scleroderma	0.00269	0.00275	CcSEcCtD
Valrubicin—Chest pain—Mycophenolic acid—systemic scleroderma	0.00268	0.00274	CcSEcCtD
Valrubicin—Myalgia—Mycophenolic acid—systemic scleroderma	0.00268	0.00274	CcSEcCtD
Valrubicin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00267	0.00273	CcSEcCtD
Valrubicin—Asthenia—Mometasone—systemic scleroderma	0.00267	0.00273	CcSEcCtD
Valrubicin—Irritability—Prednisone—systemic scleroderma	0.00266	0.00273	CcSEcCtD
Valrubicin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00264	0.00271	CcSEcCtD
Valrubicin—Pruritus—Mometasone—systemic scleroderma	0.00263	0.00269	CcSEcCtD
Valrubicin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00263	0.00269	CcSEcCtD
Valrubicin—Anaemia—Lisinopril—systemic scleroderma	0.00262	0.00268	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00259	0.00266	CcSEcCtD
Valrubicin—Body temperature increased—Captopril—systemic scleroderma	0.00258	0.00264	CcSEcCtD
Valrubicin—Abdominal pain—Captopril—systemic scleroderma	0.00258	0.00264	CcSEcCtD
Valrubicin—Nausea—Pentoxifylline—systemic scleroderma	0.00256	0.00262	CcSEcCtD
Valrubicin—Malaise—Lisinopril—systemic scleroderma	0.00255	0.00261	CcSEcCtD
Valrubicin—Diarrhoea—Mometasone—systemic scleroderma	0.00254	0.0026	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00245	0.00251	CcSEcCtD
Valrubicin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00244	0.0025	CcSEcCtD
Valrubicin—Chest pain—Lisinopril—systemic scleroderma	0.00241	0.00247	CcSEcCtD
Valrubicin—Myalgia—Lisinopril—systemic scleroderma	0.00241	0.00247	CcSEcCtD
Valrubicin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0024	0.00246	CcSEcCtD
Valrubicin—Discomfort—Lisinopril—systemic scleroderma	0.00238	0.00244	CcSEcCtD
Valrubicin—Vomiting—Mometasone—systemic scleroderma	0.00236	0.00242	CcSEcCtD
Valrubicin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00235	0.0024	CcSEcCtD
Valrubicin—Rash—Mometasone—systemic scleroderma	0.00234	0.0024	CcSEcCtD
Valrubicin—Asthenia—Captopril—systemic scleroderma	0.00234	0.0024	CcSEcCtD
Valrubicin—Dermatitis—Mometasone—systemic scleroderma	0.00234	0.0024	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00234	0.00239	CcSEcCtD
Valrubicin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00233	0.00238	CcSEcCtD
Valrubicin—Headache—Mometasone—systemic scleroderma	0.00233	0.00238	CcSEcCtD
Valrubicin—Pruritus—Captopril—systemic scleroderma	0.00231	0.00236	CcSEcCtD
Valrubicin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.0023	0.00236	CcSEcCtD
Valrubicin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00235	CcSEcCtD
Valrubicin—Abdominal pain—Azathioprine—systemic scleroderma	0.00225	0.0023	CcSEcCtD
Valrubicin—Body temperature increased—Azathioprine—systemic scleroderma	0.00225	0.0023	CcSEcCtD
Valrubicin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00229	CcSEcCtD
Valrubicin—Diarrhoea—Captopril—systemic scleroderma	0.00223	0.00229	CcSEcCtD
Valrubicin—Irritability—Methotrexate—systemic scleroderma	0.00223	0.00228	CcSEcCtD
Valrubicin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00222	0.00227	CcSEcCtD
Valrubicin—Nausea—Mometasone—systemic scleroderma	0.00221	0.00226	CcSEcCtD
Valrubicin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0022	0.00225	CcSEcCtD
Valrubicin—Hyperglycaemia—Prednisone—systemic scleroderma	0.00218	0.00223	CcSEcCtD
Valrubicin—Dizziness—Captopril—systemic scleroderma	0.00216	0.00221	CcSEcCtD
Valrubicin—Abdominal pain—Leflunomide—systemic scleroderma	0.00213	0.00218	CcSEcCtD
Valrubicin—Body temperature increased—Leflunomide—systemic scleroderma	0.00213	0.00218	CcSEcCtD
Valrubicin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00211	0.00216	CcSEcCtD
Valrubicin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00216	CcSEcCtD
Valrubicin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00216	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00211	0.00216	CcSEcCtD
Valrubicin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0021	0.00215	CcSEcCtD
Valrubicin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00214	CcSEcCtD
Valrubicin—Vomiting—Captopril—systemic scleroderma	0.00207	0.00212	CcSEcCtD
Valrubicin—Rash—Captopril—systemic scleroderma	0.00206	0.00211	CcSEcCtD
Valrubicin—Dermatitis—Captopril—systemic scleroderma	0.00206	0.0021	CcSEcCtD
Valrubicin—Headache—Captopril—systemic scleroderma	0.00204	0.00209	CcSEcCtD
Valrubicin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00203	0.00208	CcSEcCtD
Valrubicin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00203	0.00208	CcSEcCtD
Valrubicin—Diarrhoea—Azathioprine—systemic scleroderma	0.00195	0.00199	CcSEcCtD
Valrubicin—Nausea—Captopril—systemic scleroderma	0.00194	0.00198	CcSEcCtD
Valrubicin—Asthenia—Leflunomide—systemic scleroderma	0.00193	0.00198	CcSEcCtD
Valrubicin—Feeling abnormal—Lisinopril—systemic scleroderma	0.0019	0.00195	CcSEcCtD
Valrubicin—Pruritus—Leflunomide—systemic scleroderma	0.0019	0.00195	CcSEcCtD
Valrubicin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00189	0.00193	CcSEcCtD
Valrubicin—Dysuria—Methotrexate—systemic scleroderma	0.00189	0.00193	CcSEcCtD
Valrubicin—Dizziness—Azathioprine—systemic scleroderma	0.00188	0.00193	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00189	CcSEcCtD
Valrubicin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00184	0.00188	CcSEcCtD
Valrubicin—Diarrhoea—Leflunomide—systemic scleroderma	0.00184	0.00188	CcSEcCtD
Valrubicin—Body temperature increased—Lisinopril—systemic scleroderma	0.00183	0.00187	CcSEcCtD
Valrubicin—Abdominal pain—Lisinopril—systemic scleroderma	0.00183	0.00187	CcSEcCtD
Valrubicin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00181	0.00186	CcSEcCtD
Valrubicin—Vomiting—Azathioprine—systemic scleroderma	0.00181	0.00185	CcSEcCtD
Valrubicin—Pneumonia—Methotrexate—systemic scleroderma	0.00181	0.00185	CcSEcCtD
Valrubicin—Rash—Azathioprine—systemic scleroderma	0.0018	0.00184	CcSEcCtD
Valrubicin—Dermatitis—Azathioprine—systemic scleroderma	0.00179	0.00184	CcSEcCtD
Valrubicin—Headache—Azathioprine—systemic scleroderma	0.00178	0.00183	CcSEcCtD
Valrubicin—Dizziness—Leflunomide—systemic scleroderma	0.00178	0.00182	CcSEcCtD
Valrubicin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00176	0.0018	CcSEcCtD
Valrubicin—Haematuria—Methotrexate—systemic scleroderma	0.00171	0.00176	CcSEcCtD
Valrubicin—Vomiting—Leflunomide—systemic scleroderma	0.00171	0.00175	CcSEcCtD
Valrubicin—Dizziness—Mycophenolic acid—systemic scleroderma	0.0017	0.00174	CcSEcCtD
Valrubicin—Rash—Leflunomide—systemic scleroderma	0.0017	0.00174	CcSEcCtD
Valrubicin—Dermatitis—Leflunomide—systemic scleroderma	0.00169	0.00173	CcSEcCtD
Valrubicin—Nausea—Azathioprine—systemic scleroderma	0.00169	0.00173	CcSEcCtD
Valrubicin—Headache—Leflunomide—systemic scleroderma	0.00168	0.00172	CcSEcCtD
Valrubicin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00171	CcSEcCtD
Valrubicin—Asthenia—Lisinopril—systemic scleroderma	0.00166	0.0017	CcSEcCtD
Valrubicin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00169	CcSEcCtD
Valrubicin—Pruritus—Lisinopril—systemic scleroderma	0.00163	0.00167	CcSEcCtD
Valrubicin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00163	0.00167	CcSEcCtD
Valrubicin—Rash—Mycophenolic acid—systemic scleroderma	0.00162	0.00166	CcSEcCtD
Valrubicin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00162	0.00165	CcSEcCtD
Valrubicin—Headache—Mycophenolic acid—systemic scleroderma	0.00161	0.00165	CcSEcCtD
Valrubicin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0016	0.00164	CcSEcCtD
Valrubicin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0016	0.00164	CcSEcCtD
Valrubicin—Nausea—Leflunomide—systemic scleroderma	0.0016	0.00164	CcSEcCtD
Valrubicin—Diarrhoea—Lisinopril—systemic scleroderma	0.00158	0.00162	CcSEcCtD
Valrubicin—Ill-defined disorder—Prednisone—systemic scleroderma	0.00156	0.0016	CcSEcCtD
Valrubicin—Anaemia—Prednisone—systemic scleroderma	0.00155	0.00159	CcSEcCtD
Valrubicin—Dizziness—Lisinopril—systemic scleroderma	0.00153	0.00156	CcSEcCtD
Valrubicin—Nausea—Mycophenolic acid—systemic scleroderma	0.00152	0.00156	CcSEcCtD
Valrubicin—Malaise—Prednisone—systemic scleroderma	0.00152	0.00155	CcSEcCtD
Valrubicin—Vomiting—Lisinopril—systemic scleroderma	0.00147	0.0015	CcSEcCtD
Valrubicin—Rash—Lisinopril—systemic scleroderma	0.00146	0.00149	CcSEcCtD
Valrubicin—Dermatitis—Lisinopril—systemic scleroderma	0.00146	0.00149	CcSEcCtD
Valrubicin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00149	CcSEcCtD
Valrubicin—Headache—Lisinopril—systemic scleroderma	0.00145	0.00148	CcSEcCtD
Valrubicin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00147	CcSEcCtD
Valrubicin—Myalgia—Prednisone—systemic scleroderma	0.00143	0.00147	CcSEcCtD
Valrubicin—Discomfort—Prednisone—systemic scleroderma	0.00141	0.00145	CcSEcCtD
Valrubicin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00142	CcSEcCtD
Valrubicin—Nausea—Lisinopril—systemic scleroderma	0.00137	0.00141	CcSEcCtD
Valrubicin—Back pain—Methotrexate—systemic scleroderma	0.00136	0.00139	CcSEcCtD
Valrubicin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00137	CcSEcCtD
Valrubicin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.0013	0.00133	CcSEcCtD
Valrubicin—Anaemia—Methotrexate—systemic scleroderma	0.0013	0.00133	CcSEcCtD
Valrubicin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00132	CcSEcCtD
Valrubicin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00131	CcSEcCtD
Valrubicin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00131	CcSEcCtD
Valrubicin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00127	0.0013	CcSEcCtD
Valrubicin—Malaise—Methotrexate—systemic scleroderma	0.00127	0.0013	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00125	0.00128	CcSEcCtD
Valrubicin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00123	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—systemic scleroderma	0.0012	0.00122	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—systemic scleroderma	0.0012	0.00122	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—systemic scleroderma	0.00118	0.00121	CcSEcCtD
Valrubicin—Feeling abnormal—Prednisone—systemic scleroderma	0.00113	0.00116	CcSEcCtD
Valrubicin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00112	0.00115	CcSEcCtD
Valrubicin—Body temperature increased—Prednisone—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Valrubicin—Abdominal pain—Prednisone—systemic scleroderma	0.00108	0.00111	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00104	0.00107	CcSEcCtD
Valrubicin—Asthenia—Prednisone—systemic scleroderma	0.000985	0.00101	CcSEcCtD
Valrubicin—Pruritus—Prednisone—systemic scleroderma	0.000971	0.000994	CcSEcCtD
Valrubicin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000945	0.000968	CcSEcCtD
Valrubicin—Diarrhoea—Prednisone—systemic scleroderma	0.000939	0.000961	CcSEcCtD
Valrubicin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000938	0.00096	CcSEcCtD
Valrubicin—Dizziness—Prednisone—systemic scleroderma	0.000907	0.000929	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—systemic scleroderma	0.000907	0.000928	CcSEcCtD
Valrubicin—Body temperature increased—Methotrexate—systemic scleroderma	0.000907	0.000928	CcSEcCtD
Valrubicin—Vomiting—Prednisone—systemic scleroderma	0.000873	0.000893	CcSEcCtD
Valrubicin—Rash—Prednisone—systemic scleroderma	0.000865	0.000886	CcSEcCtD
Valrubicin—Dermatitis—Prednisone—systemic scleroderma	0.000864	0.000885	CcSEcCtD
Valrubicin—Headache—Prednisone—systemic scleroderma	0.00086	0.00088	CcSEcCtD
Valrubicin—Asthenia—Methotrexate—systemic scleroderma	0.000823	0.000842	CcSEcCtD
Valrubicin—Nausea—Prednisone—systemic scleroderma	0.000815	0.000834	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—systemic scleroderma	0.000811	0.000831	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—systemic scleroderma	0.000785	0.000803	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—systemic scleroderma	0.000758	0.000776	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—systemic scleroderma	0.000729	0.000747	CcSEcCtD
Valrubicin—Rash—Methotrexate—systemic scleroderma	0.000723	0.00074	CcSEcCtD
Valrubicin—Dermatitis—Methotrexate—systemic scleroderma	0.000722	0.00074	CcSEcCtD
Valrubicin—Headache—Methotrexate—systemic scleroderma	0.000718	0.000736	CcSEcCtD
Valrubicin—Nausea—Methotrexate—systemic scleroderma	0.000681	0.000697	CcSEcCtD
